Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > ARCHIVE
ARCHIVE
- Qol Opens Dispensing Pharmacy at Major Electronics Retail Store
August 15, 2011
- Nichi-Iko to Strengthen Relationships with Wholesalers
August 15, 2011
- NCVC to Expand Infrastructure for 1st-in-human Studies for Medical Devices
August 15, 2011
- FIRM Starts Activities Creating 3 WGs
August 15, 2011
- Daiichi Sankyo to Expand Hybrid Business Model in Mexico
August 15, 2011
- Combination Drugs Are Part of Innovation: Prof. Kaku of Kawasaki Medical School
August 15, 2011
- Statistics
August 15, 2011
- DSP Not Planning Full-scale Entry into Generic Business: President Tada
August 15, 2011
- Korosho Forecasts 92,000 Patients Admitted for Dementia in 2026
August 15, 2011
- Korosho's Study Group Proposes Qualifications for GMP Inspectors
August 15, 2011
- Fuji Pharma: Sales Up 7% Driven by Hormonal Drugs
August 15, 2011
- M3 Survey of Doctors Finds Differences in Ways Companies Detail AD Treatments
August 15, 2011
- Fee-for-Service Reimbursement to Be Permitted for Wider Range of High-priced Drugs
August 15, 2011
- SRUVEY
August 15, 2011
- Female Life Expectancy Down Slightly in 2010; First Decline in 5 Years
August 15, 2011
- PMDA to Initiate Clinical Trial Consultation for Orphan Drugs
August 15, 2011
- Takeda Discontinues Development of Anti-obesity Drug in US
August 15, 2011
- Growth in Diabetes Drug Market Driven by DPP-4 Inhibitors in 2010: Yano Research
August 15, 2011
- JPA President Kodama to Explain about Leaked Copy of His Appeal at General Assembly
August 15, 2011
- NCCHD Creates Pediatric Clinical Trial Network of 27 Facilities
August 15, 2011
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…